Gurianova, Margarita Anatolevna, V. I. Kazey, O. A. Shukhov, E. Yu. Chelysheva, A. G. Nikiforova, P. D. Sobolev, M. S. Dolov, et al. “Interim Results of the Russian Prospective Multi-Center Clinical Trial READIT-2020 (Reduction of Tyrosine Kinase Inhibitor Doses in CML Patients, Plasma Imatinib Nilotinib Concentrations, Sustaining Molecular Response, and Drug Toxicity)”. Clinical Oncohematology. Basic Research and Clinical Practice 17, no. 4 (October 1, 2024): 347–359. Accessed November 11, 2025. https://bloodjournal.ru/index.php/coh/article/view/101.